BAYER
In 2014, Peking University and Bayer signed a comprehensive collaboration agreement on a strategic partnership to promote translational research for drug discovery. Under this agreement, the two partners established a joint research center at Peking University under the name of Bayer HealthCare/Peking University Center of Translational Research for Drug Discovery (BPC/TRDD). In addition, Bayer provides funding support on joint research projects as well as grants for Bayer Endowed Chairs, Bayer Investigators and Bayer Postdocs (since 2016) in recognition of scientific excellence and outstanding contributions to life sciences, with a focus on drug discovery and innovation in the key therapeutic areas of Bayer.
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability, and quality throughout the world. In fiscal year 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros. For more information, go to www.bayer.com